MD # 7807 DLM/kg. At the time of death, comparable brain DLM concentrations were present in weanling and adult rats that received 12 and 80 mg DLM/kg po, respectively. Sheets (2000) proposed that the greater sensitivities of rat pups to lethal doses of Type II pyrethroids were due to limited metabolic capacity, though no data on the age-dependency of biotransformation of pyrethroids were located.
DLM has been studied in adults, but information on its metabolism and disposition in immature laboratory animals and humans is very limited. DLM appeared to be rapidly, but poorly absorbed from the gastrointestinal (GI) tract of adult rats, disparately distributed in different brain regions, and oxidized in the liver to 4'-hydroxy DLM (Anàdon et al., 1996) . Gray and Rickard (1981) observed substantially higher radioactivity levels in plasma than in brain over time following iv injection of adult rats with 14 C-labeled DLM. Levels in fat were significantly higher than in other tissues. DLM and other pyrethroids are metabolized in adult male rats and mice by ester cleavage and by cytochome P450 (CYP)-catalyzed hydroxylation, with subsequent glucuronidation and sulfation ( Fig. 1 ) (Ruzo et al., 1978 (Ruzo et al., , 1979 Soderlund and Casida, 1977) .
Pyrethroids with a cyano group (e.g., DLM) were the least prone to ester hydrolysis and CYP oxidation. Anand et al. (2005) recently reported that adult male rat hepatic CYPs, notably CYP1A1 and CYP1A2, play a more important role than hepatic microsomal and plasma carboxylesterases (CaEs) in biotransformation of DLM in vitro. Relatively low intrinsic clearance by plasma CaEs indicated that detoxification in the bloodstream should be modest compared to that in the liver.
A major objective of the present study was to characterize the ontogeny of DLM metabolism in the maturing male Sprague-Dawley rat. One aim was to conduct a qualitative and quantitative in vitro comparison of DLM biotransformation in the maturing rat with that observed previously in the adult (Anand et al., 2005) . A related aim was to assess the influence of maturation on in MD # 7807
Materials and Methods
Chemicals. DLM ((S)-alpha-cyano-3-phenoxybenzyl-(1R,cis)-2,2-dimethyl-3-(2,2-dibromvinyl)-cyclopropanecarboxylate) was obtained from ChemService (Westchester, PA, 98% pure). Acetonitrile (HPLC-grade) was procured from Burdick and Jackson (Muskegon, MI).
Tetra isopropyl pyrophosphoramide (isoOMPA) was purchased from Sigma Chemical Co (St.
Louis, MO). All other chemicals were of analytical grade.
Animals. and adult male Sprague-Dawley (SD) rats were obtained from Charles River Inc. (Raleigh, NC). The rats were housed individually and allowed water and food (Purina Rat Chow 5001; Purina, St. Louis, MO) ad libitum. The AAALAC-approved animal care facility was maintained at 72±2 º F and 50±10% humidity with a 12-h light/dark cycle. The experimental protocol was reviewed and approved by the University of Georgia Animal Care Committee. The day each litter was born was considered postnatal day 0 (PND0).
On PND3, pups were sexed and a total of 8 pups housed with each dam. The pups (largely males)
were housed with dams until sacrifice on PND10 or upon weaning (PND21). The remaining pups were housed separately (5/cage) until PND40, when they were utilized. Only male rats were used for the DLM metabolism workups for each age-group.
Plasma and Liver Microsome Preparation.
Male rat pups of different ages (10-, 21-, and 40-d) were sacrificed by cervical dislocation, and blood and liver samples collected. Blood was drawn by cardiac puncture and centrifuged at 2500xg for 10 min in a Microfuge 22R centrifuge (Beckman Coulter   TM , Atlanta, GA) to obtain plasma. The plasma was frozen at -80 º C until the time of use. It was necessary to combine the livers and plasma of 12 -14 PND10 pups (interlitter pool) and 7 -8 PND21 pups (intra-litter pool) to obtain a total of ~ 5 g liver and 2.5 ml plasma. Four separate pooled liver and plasma composites per age-group were obtained for procedure. Because the liver microsomes were resuspended in a volume of buffer the same as the original volume of liver, enzyme activities measured in each ml of suspension could be expressed per g liver (Anand et al., 2005) .
In Vitro Metabolism of DLM. The kinetics of DLM metabolism in plasma and hepatic microsomes was evaluated by measuring the rate of disappearance of parent compound.
Hydroxylated metabolites of DLM are not commercially available to use as standards. Initial experiments (data not shown) were conducted to verify the optimal incubation conditions for each assay (plasma CaEs, liver CaEs and liver CYPs). Disappearance of DLM was linear with respect to time and tissue concentration over the DLM concentration ranges relevant to this study.
Separate incubations were performed for plasma and liver microsomal CaEs-and CYPs-mediated metabolism. In vitro incubations of each liver or plasma sample from the 10-, 21-and 40-d-old pups were conducted concurrently. Incubation conditions varied with the animal donors' age, as described below. The velocity (Vo) of each reaction was expressed as nmol DLM disappearance/h/g liver or ml plasma. CaE metabolism was characterized using the inhibitor isoOMPA (1 mM in plasma and 24 mM in liver, final concentration). Details on the choice and This article has not been copyedited and formatted. The final version may differ from this version. efficacy of the CaE inhibitor (i.e., isoOMPA) have been described in our previous report (Anand et al., 2005) . NADPH-dependent metabolism was considered as CYP-mediated detoxification.
Plasma Metabolism of DLM. Various concentrations (2, 10, 20, 100 and 200 µM final) of DLM were incubated at 37 º C with 500 µl of Tris-HC1 buffer (pH 7.4)-diluted plasma (40% for PND10 and 30% for PND21 and 40). The incubation times were 120 min for PND10 and 21 and 60 min for PND40. One set of plasma samples was preincubated with isoOMPA for 1 h for CaE inhibition (Anand et al., 2005) before addition of DLM. The reaction was initiated by adding 500 µl of diluted ice-cold plasma (with or without isoOMPA) to 5 µl of various DLM concentrations (in acetonitrile, never more than 1% of total volume). Similar incubations were conducted with Tris-HC1 buffer, which served as a non-enzymatic control. After respective incubation periods, 1.5 ml of acetonitrile were added for DLM extraction and analysis, as described below. The difference in DLM concentrations, between tubes with and without isoOMPA, was considered to be due to CaE-mediated metabolism.
Liver Microsomal Metabolism of DLM.
Liver CaEs: Liver microsomes from PND10 (1:2 dilution, ~ 10 mg protein/ml), PND21 (1:5 dilution, ~ 4 mg protein/ml) and PND40 (1:10 dilution, ~ 2 mg protein/ml) pups were preincubated with or without 10 µl isoOMPA for 1 h at room temperature. One ml of ice-cold microsomes with or without isoOMPA was added to 10 µl of a series of concentrations of DLM (2, 10, 20, 100 and 200 µM final) to initiate the reaction. PND10 microsomes were incubated for 60 min, while PND21 and 40 microsomes were incubated for 30 min at 37 º C. A buffer control was included to account for background hydrolysis. At the end of the incubation periods, 3 ml of acetonitrile were added to the incubation mixture to stop the reaction and to extract the DLM.
DLM extraction and analysis are described below. The difference in DLM concentrations guard column (10 mm long x 4.6 mm internal diameter). The mobile phase was 70:30 acetonitrile/1% sulfuric acid at a flow rate of 1 ml/min. Peak heights were quantified at 230 nm by the external standard technique using standard solutions of DLM (5 ng to 10 µg).
Since we have recently measured and reported (Anand et al., 2005) metabolic rate constants for adult rats (PND90), these data were included in the present report. Nonetheless, in vitro incubations of PND90 liver microsomes and plasma were performed along with other ages with the lowest (2 µM) and highest (200 µM) DLM concentrations to determine whether there was significant day-to-day variability in experimental results. This proved not be the case, so the previously published PND90 data were used here to compare with immature rat data.
Assessment of toxic signs and blood DLM levels in vivo.
The objective of this phase of the study was to assess the age-dependency of toxicity and of internal DLM exposure following administration of equivalent dose of DLM to young and adult rats, and so in vivo findings could be related to the in vitro metabolism data. Ten-, 21-, 40-and 90-d-old male SD rats received 10 mg DLM/kg in glycerol formal by gavage. This dose was selected on the basis of our own preliminary studies and the LD50 data of Sheets et al. (1994) . Since there are no widely accepted biochemical markers for pyrethroid neurotoxicity (Soderlund et al., 2002) , our rats were monitored for commonly-manifested signs: salivation, tremors and lethality. The signs were evaluated (n=4) periodically for up to 6 h after DLM exposure. The salivation was graded using the following scoring system: 0 -no saliva; 1 -wet area around the mouth and nose (mild); 2 -wet area around the mouth, nose and some on the neck (moderate); 3 -entire mouth, nose and neck covered with saliva (severe). The severity of tremors was graded as follows: 0 -no tremor;
-violent tremor and no voluntary control of movement (severe). The observer was blinded to the treatment of the rats.
Rats (n=3 or 4) of each age were serially sacrificed from 15 min to 24 h post dosing to collect blood and selected tissues for analyses of DLM. Because of 100% mortality, it was possible to collect samples only up to 6 and 12 h for PND10 and 21 animals, respectively. The blood samples were processed immediately for DLM analysis as described by Kim et al. (2005) . Only blood DLM profiles and toxicity data are presented here. The tissue DLM profiles will be reported elsewhere. Addition of isoOMPA almost completely inhibited DLM metabolism in each age-group (Fig. 2 insert), confirming the role of CaEs in DLM biotransformation in plasma of immature rats.
Hepatic Microsomal Metabolism by CaEs. DLM metabolism by liver microsomal CaEs (Fig. 3) is age-dependent, but its developmental pattern differs in some respects from that of plasma CaEs. The male rat liver CaE metabolic capacity increases significantly with age (Table   1 ). There is roughly a 5-fold increase (p≤0.05) in liver CaE activity between PND10 and 21, in contrast to the lack of significant rise in plasma CaE activity during this period. The liver microsomal V max for PND40 rats is significantly higher than for PND10 (~ 12-fold) and 21 rats (~ 2.6-fold). Nevertheless, the PND40 V max is only 15% (p≤0.05) of that in 90-d-old adults (Table 1) . K m values remain relatively constant during maturation. Intrinsic clearance in the PND90 adults was significantly higher than in the immature age groups. The PND21 and 40
clearances were not significantly different from one another, but were higher than in PND10
pups. The addition of isoOMPA completely inhibited DLM metabolism in each immature agegroup at all the concentrations studied (Fig. 3 insert) .
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 5A ). In contrast, Anand et al. (2005) found that liver microsomal CaEs of adult male SD rats were more efficient (p≤0.05) than plasma CaEs in biotransformation of DLM, as is evident in Fig. 5A . It is worthy of note again that liver CaE activity of PND40 pups is only about 15% of that in PND90 adults (Fig. 5B) . CYP-catalyzed DLM metabolism is substantially greater than metabolism by plasma and/or hepatic microsomal CaEs at each developmental stage (Fig. 5A) . Liver CYP and plasma CaE activities increase to ~ adult levels between d 10 and 40 in the maturing male SD rats (Fig. 5B) . The relatively modest increase in liver microsomal CaE activity during this developmental period appears to be primarily responsible for the 40-d-old rats' inability to attain adult DLM metabolic capacity (Fig. 5B ). plateau in the 10-and 21-d-old rats. Pronounced toxicity likely contributed to the unusual kinetic profiles in the latter two groups. AUCs are truncated at 6 and 12 h, due to the death of each PND10 and 21 animal soon after these times, respectively (Fig. 6B) . In each instance, the AUCs vary inversely with age. Age-dependent decreases in blood AUCs were statistically significant except the decrease noted between PND40 and 90. The Cmaxs also appeared to progressively decrease with increasing age, though the PND21, 40 and 90 values were not statistically different from one another (Fig. 6C ).
DLM Internal Exposure and
The severity of signs of DLM neurotoxicity was inversely related to age (Table 2 ). It is evident that the most pronounced salivation and tremors were experienced by the youngest rats.
Both manifestations of neurotoxicity increased over time following dosing in the PND10 and 21
animals. This was particularly true for tremors. All of the PND10 and 21 rats died between 6-8 h and 12-16 h, respectively. None of the PND40 or 90 rats succumbed. No tremors were observed in the members of either older group. Salivation was mild (PND90) to moderate (PND40) and lasted only 2 to 3 h.
There was concordance between the severity of acute neurotoxic signs and the magnitude of systemic DLM exposure. Total scores were obtained for salivation and for tremors by summing the 1-, 2-, 3-, 4-, and 6-h scores in Table 2 for each age-group. These total scores for each toxic sign were plotted against the groups' blood DLM AUCs (0-6 h for PND10 and 0-12 h for PND21, 40 and 90 rats) (Fig. 7) . There was a good correlation between AUCs and severity of salivation (r 2 -0.87) and between AUCs and severity of tremors (r 2 -0.90). Lower correlation coefficients were obtained when relating to the total toxicity scores to Cmax values (r 2 -0.63 for salivation vs Cmax; r 2 -0.70 for tremors vs Cmax) (data not shown).
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Discussion
An important aim of this study was to test the hypothesis that inefficient metabolic detoxification is a contributing factor to the greater susceptibility of neonatal and weanling rats to acute DLM neurotoxicity. Sheets et al. (1994) clearly showed that DLM toxicity varied with age of immature Long-Evans rats. In the present study, 10-and 21-d-old male SD rats gavaged with 10 mg DLM/kg exhibited pronounced salivation and tremors leading to 100% mortality between 6 -8 h and 12 -16 h in the PND10 and 21 groups, respectively. PND40 and 90 rats receiving the same dose experienced only transient salivation, and all the rats survived. Decreased internal exposure to DLM during maturation, as evidenced by AUCs and Cmaxs (Figs. 6B and C) paralleled the severity of poisoning (Table 2) . AUC ( Fig. 7) showed a higher degree of correlation with toxic signs than did Cmax (data not shown). DLM metabolism in vitro by plasma and liver CaEs and hepatic CYPs exhibited progressive increases with maturation (Table 1) .
These findings strongly support the aforementioned hypothesis.
There has been a paucity of recent data on the metabolism and systemic disposition of DLM and other pyrethroids, despite their rapidly expanding use in the U.S. and other countries. This is particularly true of immature laboratory animals and humans. Anand et al. (2005) identified and clarified the relative contributions of liver CYPs and liver and plasma CaEs to DLM metabolism in adult, male SD rats. The current study is the first to characterize the ontogeny of DLM metabolism. The age-dependent increases in the capacity of plasma CaEs and CYPs to detoxify DLM reach adult levels by 40 d, but the contribution of liver CaEs is more limited in the PND40 rats than in adults (Fig. 5) . These data are in agreement with the agedependent reductions in blood DLM levels ( Fig. 6 ) and toxic signs ( Table 2 ). The findings should be generally applicable to other pyrethroids, though the extent to which these compounds are hydrolyzed and oxidized depends upon their isomerization and substitutions (Soderlund and This article has not been copyedited and formatted. The final version may differ from this version. Casida, 1977) . Age-, sex-or species-dependent differences may assume greater importance in the detoxification of pyrethroids that are designed to be metabolically stable than would be the case with very rapidly metabolized congeners.
Plasma and hepatic microsomal CaEs that cleave DLM exhibit different developmental profiles. Intrinsic clearance of DLM by plasma CaEs nearly matches adult levels by PND40.
Intrinsic clearance by liver CaEs at PND40 is only about 15% of that in adult rats (Fig. 5) ,
suggesting that liver CaEs undergo substantial maturational changes between PND40 and 90.
Investigations of the heightened sensitivity of young rats to acute organophosphate toxicity also reveal age-related increases in the activities of plasma and liver CaEs, but most of these developmental data are limited to preweanling rats (Karanth and Pope, 2000; Moser et al., 1998) . Sterri et al. (1985) report that plasma CaE activity in male Wistar rats reaches adult levels by PND30, but that liver CaE activity is still only 70 -80% of that in adults. In contrast, Morgan and coworkers (1994) reported that liver CaE activity reached adult levels by 42 d, but these researchers evaluated just two isozymes (hydrolases A and B). The relationship of these isozymes to the metabolism of DLM is not known. The significantly lower metabolic capacity of PND40 than PND90 liver CaEs than (Fig. 5 ) apparently reflects the relatively slow development of hepatic CaEs that cleave DLM.
There are apparently qualitative, as well as marked quantitative age-related differences in both rat plasma and liver CaEs that metabolize DLM (Table 1 ). There is relatively little variation in plasma or liver K m values during this developmental period. Bell and Ecobichon (1975) used α -naphthyl acetate as a substrate to monitor CaE activity in the S9 liver supernatant of unsexed Wistar rats, ranging in age from 3 days prepartum to PND35. These researchers report a progressive decrease in K m from prepartum day 3 to PND 14, followed by a progressive rise through PND 35. Adult K m values were not reported. We, like Bell and Ecobichon (1975) , This article has not been copyedited and formatted. The final version may differ from this version. (Satoh and Hosokawa, 1998) . Maturational changes associated with different isoforms and structural modifications may contribute to the modest qualitative and marked quantitative changes, as well as the differences in the developmental profile we observed in rat plasma and liver CaEs that metabolize DLM.
DLM metabolism in vitro by CYP is substantially greater than by plasma or liver CaEs in maturing male S-D rats (Table 1) , as is the case in adults (Anand et al., 2005) . This finding is supported by the results of an in vivo toxicity and metabolism study by Ruzo et al. (1979) . These investigators found that pretreatment of mice with tributyl phosphorothionate, an esterase inhibitor, decreased urinary DLM metabolite excretion and also decreased the LD50 by 2-fold.
Pretreatment of mice with piperonyl butoxide, a CYP inhibitor, inhibited metabolite excretion and produced a 3-to 5-fold decrease in LD 50 . Age-dependent increase in the intrinsic clearance by CYP in the current study was mainly due to increases in Vmax, not Km. Intrinsic clearance by CYP reached adult levels by PND40, but adult V max and K m values were still significantly higher than PND40 values. The differences between 40 and 90 d may be associated with maturational changes in the CYPs associated with DLM biotransformation.
The identity of the CYP enzyme(s) that metabolize DLM has not been thoroughly investigated, although CYP1A1/2 and CYP2B1/2 are implicated. Using commercially available rat CYP enzymes, Anand et al. (2005) found that CYP1A1 and CYP1A2 were quite effective, and CYP2C11 exhibited modest activity in transforming DLM in vitro. Dayal et al. (1999) reported induction of CYP1A1/2 and CYP2B1/2 activities in liver following repeated (7-, 15-or 21-d) exposures to DLM. While reports on developmental changes (Atterberry et al., 1997;  This article has not been copyedited and formatted. The final version may differ from this version. Gebremichael et al., 1995) of CYP1A1/2 and CYP2B1/2 activities are contradictory, ontogeny of DLM metabolism (Table 1) is not in accordance with the developmental changes of these enzymes. The possible reasons could be: 1) ethoxyresorufin O-deethylase and pentoxyresorufin O-dealkylase are usually considered to be catalyzed by CYP1A1/2 and CYP2B1/2, respectively, but other CYPs (i.e., CYP2C6 and 2C11) also contribute to deethylase and dealkylase activities (Kobayashi et al., 2002) ; and 2) there is no consensus on constitutive protein expression of CYP1A1/2 and CYP2B1/2 in rats (Agarwal and Shapiro 2003; de Waziers et al., 1990) .
We did recently find that among the commercially available human CYP enzymes, CYP1A1, 1A2 and 2B6 were capable of metabolizing DLM (unpublished data). This suggests that the same enzymes could metabolize DLM in rats and humans. Constitutive CYP1A1 expression is often undetectable in adult human liver, and the developmental profile of CYP2B6 is largely unknown (Hines and McCarver, 2002) . Sonnier and Cresteil (1998) demonstrated that CYP1A2 expression was absent in the liver of human neonates, gradually increased in infants, but was still only onehalf that in adults. While human CaEs that metabolize DLM have not yet been identified, a limited study of the maturational expression of human liver CaEs showed that activity in 5 infants < 2 years old was not significantly lower than 5 adults (Pope et al., 2005) . There may well be qualitative and quantitative interspecies differences in enzymes involved in DLM biotransformation. Nevertheless, the general deficit in CaEs and CYPs in the more immature humans and rodents suggest that these age-groups of both species will be particularly susceptible to acute DLM neurotoxicity.
In summary, the age-dependent increase in the DLM metabolism in vitro is consistent with the age-dependent decreases in the blood DLM levels and toxicity in vivo. Nevertheless, it should be recognized that age-dependent pharmacokinetic factors other than metabolism may also affect the bioavailability of DLM and the magnitude of its adverse effects. Preweanling rats This article has not been copyedited and formatted. The final version may differ from this version. are shown to have relatively high GI absorption rates (Hoffman, 1982; Naylor and Harrison, 1995) . P-glycoprotein, which may play a role as an efflux transporter of pyrethroids (Bain and LeBlanc, 1996; Buss et al., 2002) have been found to be deficient in young mice (Mahmood et al., 2001) . Extensive absorption and/or decreased efflux from the GI tract of young could contribute to the higher internal exposure and toxicity of DLM. Adult rats have larger amounts of body fat than perinatal animals. This may contribute to greater deposition of the highly lipophilic compound in the young animal's brain, as could an ineffectual blood-brain barrier. Srinivas et al. This article has not been copyedited and formatted. The final version may differ from this version.
